Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Aug 14, 2026
Knowledge, beliefs, perceived barriers, and previous upper gastrointestinal endoscopy use regarding Helicobacter pylori and gastric cancer prevention among community residents: a cross-sectional study.
Read at PubMed CentralPubMed Central · Aug 14, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Paradigm Shifts in Perioperative Management of Colorectal Cancer: Personalization Based on Tumor Biology, Primary Site, and Recurrence Risk, and the Evolving Role of Organ Preservation.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Programmable ZBTB7A RNA N(6)-methyladenosine site-specific demethylation suppresses colorectal cancer liver metastasis.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Structure-Function Regulation of Proteolytically Stable Amphiphilic Peptide-Based Soft Materials With Antimicrobial Efficacy Against Drug-Resistant Strains and Anticancer Activity in Triple-Negative Breast Cancer Cells.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Low-Dose Intestinal Irradiation Enhances the Efficacy and Prognosis of PD-1 Blockade in Metastatic Non-Small Cell Lung Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Piggybacking toward Progress for CAR T-Cell Therapy in Prostate Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
PSA density for clinically significant prostate cancer detection: a retrospective cohort study on the influence of age and prostate volume.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review.
Read at PubMed CentralPubMed Central · Aug 14, 2026
eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Human Group IIA Secreted Phospholipase A(2) and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms.
Read at PubMed CentralPubMed Central · Aug 14, 2026
The LVI Component Hypothesis: the lymphatic-to-vascular invasion ratio as an enrichment biomarker for therapy with PD-L1×VEGF-A bispecific antibodies.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Novel Co-Occurrence of Germline EGFR p.V843I and Somatic EGFR Exon 19 Deletion in NSCLC: Insights into Reduced Sensitivity to EGFR-TKIs.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Mechanobiology of Matricellular Proteins in Bladder Cancer: A Narrative Review and Bioinformatics Analysis.
Read at PubMed Central